MyoTherix

About:

MyoTherix is a clinical-stage drug discovery and development company for patients suffering from rare neuromuscular disorders.

Website: http://www.myotherix.com

Description:

MyoTherix is a clinical-stage drug discovery and development company for patients suffering from rare neuromuscular disorders. It is a venture-supported biotechnology company focused on developing novel therapeutics for the treatment of muscle disorders. Its lead product opportunity utilizes an innovative and novel approach to target both cardiac and skeletal muscle weakness.

Total Funding Amount:

$1M

Headquarters Location:

Union City, California, United States

Founded Date:

2013-01-01

Founders:

John Kincaid, Mark De Souza, Michael G. Kelly

Number of Employees:

1-10

Last Funding Date:

2015-06-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai